Preparing your results

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Intracellular heat shock protein-70 negatively regulates TLR4 signaling in the newborn intestinal epithelium.

Necrotizing enterocolitis (NEC) is the leading cause of gastrointestinal-related mortality in premature infants, and it develops under conditions of exaggerated TLR4 signaling in the newborn intestinal epithelium. Because NEC does not develop spontaneously, despite the presence of seemingly tonic stimulation of intestinal TLR4, we hypothesized that mechanisms must exist to constrain TLR4 signaling that become diminished during NEC pathogenesis and focused on the intracellular stress response protein and chaperone heat shock protein-70 (Hsp70). We demonstrate that the induction of intracellular Hsp70 in enterocytes dramatically reduced TLR4 signaling, as assessed by LPS-induced NF-κB translocation, cytokine expression, and apoptosis. These findings were confirmed in vivo, using mice that either globally lacked Hsp70 or overexpressed Hsp70 within the intestinal epithelium. TLR4 activation itself significantly increased Hsp70 expression in enterocytes, which provided a mechanism of autoinhibition of TLR4 signaling in enterocytes. In seeking to define the mechanisms involved, intracellular Hsp70-mediated inhibition of TLR4 signaling required both its substrate-binding EEVD domain and association with the cochaperone CHIP, resulting in ubiquitination and proteasomal degradation of TLR4. The expression of Hsp70 in the intestinal epithelium was significantly decreased in murine and human NEC compared with healthy controls, suggesting that loss of Hsp70 protection from TLR4 could lead to NEC. In support of this, intestinal Hsp70 overexpression in mice and pharmacologic upregulation of Hsp70 reversed TLR4-induced cytokines and enterocyte apoptosis, as well as prevented and treated experimental NEC. Thus, a novel TLR4 regulatory pathway exists within the newborn gut involving Hsp70 that may be pharmacologically activated to limit NEC severity.

Pubmed ID: 22461698


  • Afrazi A
  • Sodhi CP
  • Good M
  • Jia H
  • Siggers R
  • Yazji I
  • Ma C
  • Neal MD
  • Prindle T
  • Grant ZS
  • Branca MF
  • Ozolek J
  • Chang EB
  • Hackam DJ


Journal of immunology (Baltimore, Md. : 1950)

Publication Data

May 1, 2012

Associated Grants

  • Agency: NIDDK NIH HHS, Id: F30 DK085930
  • Agency: NIDDK NIH HHS, Id: F30DK085930
  • Agency: NICHD NIH HHS, Id: K12 HD052892
  • Agency: NIDDK NIH HHS, Id: R01 DK083752
  • Agency: NIDDK NIH HHS, Id: R01 DK083752-05
  • Agency: NIGMS NIH HHS, Id: R01 GM078238
  • Agency: NIGMS NIH HHS, Id: R01 GM078238-05
  • Agency: NIDDK NIH HHS, Id: R01DK08752
  • Agency: NIGMS NIH HHS, Id: R01GM078238
  • Agency: NCRR NIH HHS, Id: UL1 RR024153
  • Agency: NCATS NIH HHS, Id: UL1 TR000005

Mesh Terms

  • Animals
  • Apoptosis
  • Enterocolitis, Necrotizing
  • Female
  • HSP70 Heat-Shock Proteins
  • Humans
  • Infant, Newborn
  • Intestinal Mucosa
  • Lipopolysaccharides
  • Male
  • Mice
  • NF-kappa B
  • Proteasome Endopeptidase Complex
  • Protein Structure, Tertiary
  • Proteolysis
  • Signal Transduction
  • Toll-Like Receptor 4
  • Ubiquitin-Protein Ligases
  • Ubiquitination